drugset / Trial / NCT04957940
Lipid Emulsion Infusion and COVID-19 Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
Investigators suggest that early administration of intravenous lipid emulsion (ILE) affect the inflammatory response and improve outcome in COVID-19. The aim of this trial is to study the effect of fish-oil-based intravenous lipid emulsion (FOBLE) supplementation added to enteral nutrition on shift to ICU for upgrading oxygenation \&/or ventilation in moderate cases of Covid-19 diseased patients requiring only supplemental oxygen in form of simple nasal cannula or venturi mask oxygen (during 7 days admission).
Timeline
- Start
- 2021-07-05
- Primary completion
- 2021-09-20
- Completion
- 2021-09-26
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SMOFlipid | Other / unclassified | 100 ml | Intravenous |